Aromatase Expression in Endometriosis and Its Significance
Aromatase is highly expressed in endometriosis, producing estrogen locally and contributing to disease progression, with potential therapeutic targeting by aromatase inhibitors.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This paper reviews how aromatase, the key estrogen-biosynthesis enzyme, is highly expressed in endometriotic tissue and can produce estrogen locally, potentially driving lesion growth and progression. It describes additional steroid enzyme changes (increased 17β-hydroxysteroid dehydrogenase type 1 and absent 17β-hydroxysteroid dehydrogenase type 2) that would raise tissue estrogen concentrations, and explains proposed regulatory mechanisms at the CYP19A1 transcriptional and epigenetic levels, highlighting the activity of promoter PII and CpG island hypomethylation. A stated caveat is that regulation of aromatase is complex and occurs across multiple layers, which limits straightforward causal interpretation, despite the mechanistic model presented. This paper is centrally about endometriosis — it focuses on aromatase expression and its significance for local estrogen production in endometriotic lesions and as a therapeutic target.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (93)
- Anastrazole and oral contraceptives: a novel treatment for endometriosis via openalex
- Androstenedione Up-Regulation of Endometrial Aromatase Expression via Local Conversion to Estrogen: Potential Relevance to the Pathogenesis of Endometriosis via openalex
- An epigenetic disorder may cause aberrant expression of aromatase gene in endometriotic stromal cells via openalex
- Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target via openalex
- Aromatase expression in endometriotic tissues and cell cultures of patients with endometriosis via openalex
- Aromatase inhibitors for the treatment of endometriosis via openalex
- CYP17 and CYP19 gene polymorphisms in women affected with endometriosis via openalex
- Deficient 17β-Hydroxysteroid Dehydrogenase Type 2 Expression in Endometriosis: Failure to Metabolize 17β-Estradiol<sup>1</sup> via openalex
- Demethylation of a nonpromoter cytosine-phosphate-guanine island in the aromatase gene may cause the aberrant up-regulation in endometriotic tissues via openalex
- Endometriosis via openalex
- Endometriosis: the pathophysiology as an estrogen-dependent disease via openalex
- Estrogen biosynthesis in endometriosis: molecular basis and clinical relevance via openalex
- Estrogen metabolizing enzymes in endometrium and endometriosis via openalex
- Estrogen Receptor (ER) β Regulates ERα Expression in Stromal Cells Derived from Ovarian Endometriosis via openalex
- Expression of Concern: Randomized comparison of superovulation with letrozole vs. clomiphene citrate in an IUI program for women with recently surgically treated minimal to mild endometriosis via openalex
- Expression of estrogen receptor alpha and beta in peritoneal and ovarian endometriosis via openalex
- Functional Analyses of Endometriosis-Related Polymorphisms in the Estrogen Synthesis and Metabolism-Related Genes via openalex
- Genetic association studies in female reproduction: from candidate-gene approaches to genome-wide mapping via openalex
- Genetic variation in the sex hormone metabolic pathway and endometriosis risk: an evaluation of candidate genes via openalex
- Increased Production of 17β-Estradiol in Endometriosis Lesions Is the Result of Impaired Metabolism via openalex
- Interleukin-6 and other soluble factors in peritoneal fluid and endometriomas and their relation to pain and aromatase expression via openalex
- Letrozole and norethisterone acetate versus letrozole and triptorelin in the treatment of endometriosis related pain symptoms: a randomized controlled trial via openalex
- Macrophage Migration Inhibitory Factor Is Involved in a Positive Feedback Loop Increasing Aromatase Expression in Endometriosis via openalex
- Polymorphic variants of <i><scp>CYP</scp>17</i> and <i><scp>CYP</scp>19A</i> and risk of infertility in endometriosis via openalex
- Postmenopausal endometriosis via openalex
- Prostaglandin E2 Stimulates Aromatase Expression in Endometriosis-Derived Stromal Cells via openalex
- Prostaglandin E2 Via Steroidogenic Factor-1 Coordinately Regulates Transcription of Steroidogenic Genes Necessary for Estrogen Synthesis in Endometriosis via openalex
- Prostaglandin E<sub>2</sub>Stimulates Aromatase Expression in Endometriosis-Derived Stromal Cells<sup>1</sup> via openalex
- Role of the vaginally administered aromatase inhibitor anastrozole in women with rectovaginal endometriosis: a pilot study via openalex
- Successful treatment of refractory endometriosis-related chronic pelvic pain with aromatase inhibitors in premenopausal patients via openalex
- Successful treatment of severe endometriosis in two premenopausal women with an aromatase inhibitor via openalex
- Ten Estrogen-Related Polymorphisms and Endometriosis via openalex
- The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial via openalex
- The expression of estrogen receptors as well as GREB1, c-MYC, and cyclin D1, estrogen-regulated genes implicated in proliferation, is increased in peritoneal endometriosis via openalex
- The Use of Aromatase Inhibitors for Ovulation Induction and Superovulation via openalex
- Transcriptional Activation of Steroidogenic Factor-1 by Hypomethylation of the 5′ CpG Island in Endometriosis via openalex
- Treatment of Severe Postmenopausal Endometriosis With an Aromatase Inhibitor via openalex
- W2075705125 via openalex
- W2078401381 via openalex
- W2078740802 via openalex
- W1994505064 via openalex
- W1993354065 via openalex
- W2092820035 via openalex
- W2093802928 via openalex
- W2098042580 via openalex
- W2107450549 via openalex
- W2109525253 via openalex
- W2115156634 via openalex
- W2116022066 via openalex
- W1973335161 via openalex
- W2119039069 via openalex
- W2122476299 via openalex
- W2127539255 via openalex
- W2140376253 via openalex
- W2144133819 via openalex
- W2145213731 via openalex
- W2145397125 via openalex
- W2147124650 via openalex
- W2149440394 via openalex
- W2150092182 via openalex
- W2153056118 via openalex
- W2155606878 via openalex
- W2157853773 via openalex
- W2159307196 via openalex
- W2159369450 via openalex
- W2159803441 via openalex
- W2010311297 via openalex
- W2165232862 via openalex
- W2165929198 via openalex
- W1966022542 via openalex
- W1946355969 via openalex
- W1941904566 via openalex
- W1969133243 via openalex
- W2015015687 via openalex
- W2016615147 via openalex
- W2006521167 via openalex
- W2026236675 via openalex
- W2027255665 via openalex
- W1998657660 via openalex
- W2032923154 via openalex
- W1997649672 via openalex
- W2043998814 via openalex
- W2045029663 via openalex
- W2047530251 via openalex
- W2048655938 via openalex
- W2049578688 via openalex
- W2050847082 via openalex
- W1995071598 via openalex
- W2059184499 via openalex
- W2060548158 via openalex
- W2062401068 via openalex
- W2066865081 via openalex
- W2068550156 via openalex
Cited by (2)
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- unpaywall
- last seen: 2026-06-13T06:42:57.164913+00:00